Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: A cause-effect relationship?

Metabolism: Clinical and Experimental

Volumn 59, Issue 10, 2010, Pages 1435-1441

  Peppa, Melpomeni ^a   Boutati, Eleni ^a   Koliaki, Chrysi ^a   Papaefstathiou, Nasos ^a   Garoflos, Efstathios ^a   Economopoulos, Theofanis ^a   Hadjidakis, Dimitrios ^a   Raptis, Sotirios A ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hellenic National Diabetes Center   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADRENAL INCIDENTALOMA; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID STORAGE; MALE; METABOLIC SYNDROME X; NONFUNCTIONING ADRENAL INCIDENTALOMA; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ADENOMA; ADRENAL GLAND NEOPLASMS; BLOOD; COMPLICATION; GLUCOSE TOLERANCE TEST; INCIDENTAL FINDING; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PHYSIOLOGY;

ABSORPTIOMETRY, PHOTON; ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CAUSALITY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENTAL FINDINGS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 77956947843     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.01.007     Document Type: Article

References (31)

1. Young W.F. Jr. Clinical practice. The incidentally discovered adrenal mass N Engl J Med 356 2007 601 610
2. Mansmann G., Lau J., Balk E., Rothberg M., Miyachi Y., and Bornstein S.R. The clinically inapparent adrenal mass: update in diagnosis and management Endocr Rev 25 2004 309 340
3. Chidiac R.M., and Aron D.C. Incidentalomas. A disease of modern technology Endocrinol Metab Clin North Am 26 1997 233 253
4. Aron D.C. The adrenal incidentaloma: disease of modern technology and public health problem Rev Endocr Metab Disord 2 2001 335 342 [Review]
5. Barzon L., Sonino N., Fallo F., Palu G., and Boscaro M. Prevalence and natural history of adrenal incidentalomas Eur J Endocrinol 149 2003 273 285
6. Masumori N., Adachi H., Noda Y., and Tsukamoto T. Detection of adrenal and retroperitoneal masses in a general health examination system Urology 52 1998 572 576
7. Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., and Alì A. Survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology J Clin Endocrinol Metab 85 2000 637 644
8. Fernández-Real J.M., Engel W.R., Simó R., Salinas I., and Webb S.M. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma Clin Endocrinol (Oxford) 49 1998 53 61
9. Reincke M., Fassnacht M., Väth S., Mora P., and Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 22 1996 757 761
10. Terzolo M., Pia A., Alì A., Osella G., Reimondo G., and Bovio S. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87 2002 998 1003
11. Midorikawa S., Sanada H., Hashimoto S., Suzuki T., and Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection Clin Endocrinol (Oxford) 54 2001 797 804
12. Ivović M., Vujović S., Penezić Z., Zarković M., and Drezgić M. Insulin sensitivity in patients with adrenal incidentaloma Srpski Arhiv Za Celokupno Lekarstvo 134 2006 315 319
13. Zhang W., Tang Z.Y., Wang W.Q., and Ning G. Metabolic syndrome in patients with adrenocortical adenoma Zhonghua Yi Xue Za Zhi 86 2006 3397 3400
14. Bernini G., Moretti A., Iacconi P., Miccoli P., Nami R., and Lucani B. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery Eur J Endocrinol 148 2003 213 219
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
17. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., and Sullivan G. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
18. Matsuda M., and DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
19. Tai M.M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves Diabetes Care 17 1994 152 154
20. RISC Group Investigators Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance Eur J Endocrinol 161 2009 223 230
21. Ermetici F., Malavazos A.E., Corbetta S., Morricone L., Dall'Asta C., and Corsi M.M. Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma Metabolism 56 2007 686 692
22. Carmina E., Guastella E., Longo R., Rini G., and Lobo R.A. Correlates of increased lean muscle mass in women with polycystic ovary syndrome Eur J Endocrinol 2009 [in press]
23. Aubertin-Leheudre M., Lord C., Goulet E.D., Khalil A., and Dionne I.J. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women Obesity (Silver Spring) 14 2006 2277 2283
24. Rossi R., Tauchmanova L., Luciano A., Di Martino M., Battista C., and Del Viscovo L. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features J Clin Endocrinol Metab 85 2000 1440 1448
25. Midorikawa S., Sanada H., Hashimoto S., Suzuki T., Watanabe T., and Sasano H. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes Endocr J 48 2001 167 174
26. Linos D.A., Stylopoulos N., and Raptis S.A. Adrenaloma: a call for more aggressive management World J Surg 20 1996 788 792
27. Kandaraki E., Christakou C., and Diamanti-Kandarakis E. Metabolic syndrome and polycystic ovary syndrome.. and vice versa Arq Bras Endocrinol Metabol 53 2009 227 237
28. Libè R., Dall'Asta C., Barbetta L., Baccarelli A., Beck-Peccoz P., and Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas Eur J Endocrinol 147 2002 489 494
29. Tsagarakis S., and Vassiliadi D. Thalassinos Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications J Endocrinol Invest 29 2006 471 482
30. Vassilatou E., Vryonidou A., and Michalopoulou S. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study Clin Endocrinol (Oxf) 70 2009 May 674 679
31. Barzon L., Scaroni C., and Sonino N. Risk factors and long-term follow-up of adrenal incidentalomas J Clin Endocrinol Metab 84 1999 520 526